Published in Inflamm Res on September 01, 2005
On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio. Int J Tryptophan Res (2010) 0.88
Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm Res (2012) 0.86
Identification of residues/sequences in the human riboflavin transporter-2 that is important for function and cell biology. Nutr Metab (Lond) (2015) 0.75
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun (1993) 4.00
Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun (1992) 2.64
The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun (1994) 2.44
Experimental Staphylococcus aureus arthritis in mice. Infect Immun (1991) 2.24
Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun (1997) 2.08
The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun (1997) 1.80
Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum (1990) 1.75
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol (1999) 1.68
Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun (2000) 1.65
Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.62
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke (1995) 1.58
Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun (1999) 1.52
Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol (1997) 1.51
Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis (2003) 1.38
Genistein as an anti-inflammatory agent. Inflamm Res (2003) 1.35
Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest (1998) 1.35
Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A (1994) 1.33
Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol (1994) 1.32
The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect Immun (2001) 1.30
The dual role of interferon-gamma in experimental Staphylococcus aureus septicaemia versus arthritis. Immunology (1998) 1.30
Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J Immunol (1995) 1.28
Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis. Arthritis Rheum (1996) 1.27
Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol (1990) 1.26
Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol (1995) 1.26
Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus (2000) 1.26
A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens. J Immunol Methods (1986) 1.25
Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J Immunol Methods (1984) 1.21
Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol (1994) 1.19
Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin Exp Immunol (1984) 1.19
Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol (1992) 1.19
Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis (2006) 1.18
Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol (1983) 1.18
TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J Immunol (1998) 1.18
Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect Immun (1996) 1.17
Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology (1987) 1.17
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis (2001) 1.16
Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. J Immunol (1989) 1.16
The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol (2007) 1.16
Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology (1989) 1.15
Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol (1992) 1.14
Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol (1986) 1.13
Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation (1993) 1.12
Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin Exp Immunol (1985) 1.12
Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines. Cell Immunol (1993) 1.11
Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology (1996) 1.11
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand (2001) 1.10
Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis (1994) 1.09
Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis. Arthritis Rheum (2000) 1.09
Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis (1999) 1.08
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Evaluation of gliadin antibodies for detection of coeliac disease. Scand J Gastroenterol (1983) 1.07
Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor. Scand J Immunol (1986) 1.07
Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol (1999) 1.06
The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum (2000) 1.05
Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis. Rheumatology (Oxford) (2004) 1.05
Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol (1995) 1.05
Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis (1997) 1.04
Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice. Int Arch Allergy Appl Immunol (1988) 1.03
Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. Clin Exp Immunol (1986) 1.02
Vitamin A deficiency predisposes to Staphylococcus aureus infection. Infect Immun (1996) 1.01
Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides (2000) 1.01
Role of gamma/delta T cell receptor-expressing lymphocytes in cutaneous infection caused by Staphylococcus aureus. Clin Exp Immunol (2003) 1.01
The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response. Microb Pathog (2001) 1.01
Neutrophil mediated inflammatory response in murine lupus. Autoimmunity (1993) 1.00
Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study. Neurology (2003) 1.00
Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunology (1991) 1.00
An experimental model of cutaneous infection induced by superantigen-producing Staphylococcus aureus. J Invest Dermatol (2000) 0.99
Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. J Immunol (1998) 0.98
In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen-mediated Staphylococcus aureus arthritis. Arthritis Rheum (1996) 0.98
Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy. Scand J Immunol (2007) 0.98
Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect Immun (1995) 0.98
Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology (1989) 0.97
Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator. Arthritis Rheum (1986) 0.97
The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs. Arthritis Rheum (2000) 0.96
Staphylococcal peptidoglycans induce arthritis. Arthritis Res (2001) 0.96
False positive results in class-specific rheumatoid factor (RF) assays due to interaction between RF and Fc fragments of anti-immunoglobulin indicator reagents. J Immunol Methods (1983) 0.95
Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation. Scand J Immunol (1989) 0.95
Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice. Immunology (1986) 0.95
Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum (1997) 0.95
Progression of sialadenitis in Sjögren's syndrome. Br J Rheumatol (1993) 0.94
Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes. Cell Immunol (1995) 0.94
Autoimmunity to collagen in adult periodontal disease. J Oral Pathol (1988) 0.94
Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis. Arthritis Res (2000) 0.94
Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice. Clin Immunol Immunopathol (1987) 0.93
Effect of captopril on murine systemic lupus erythematosus disease. J Hypertens Suppl (1988) 0.92
Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol (1997) 0.92
Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis. Clin Exp Immunol (1999) 0.92
Intracisternally localized bacterial DNA containing CpG motifs induces meningitis. J Immunol (2001) 0.92
Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res (2001) 0.92
Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes. Immunology (1987) 0.92
An immunoenzyme procedure for enumerating fibronectin-secreting cells. J Immunoassay (1984) 0.91
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler (2009) 0.91
Protective role of sialophorin (CD43)-expressing cells in experimental Staphylococcus aureus infection. Infect Immun (1994) 0.91
Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA/1 mice and spontaneous arthritis in MRL/lpr mice. Autoimmunity (1991) 0.91
Enhancement of antigen-specific T-cell reactivity on the affected side in stroke patients. J Neuroimmunol (1991) 0.90